Marcel Muelbaier
Grünenthal Group (Germany)(DE)Grünenthal Group (Germany)(DE)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Multiple Myeloma Research and Treatments, Click Chemistry and Applications, interferon and immune responses
Most-Cited Works
- → Design of amidobenzimidazole STING receptor agonists with systemic activity(2018)823 cited
- → Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat(2016)252 cited
- → Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis(2018)223 cited
- → PROTAC-Mediated Degradation of Bruton’s Tyrosine Kinase Is Inhibited by Covalent Binding(2019)180 cited
- → Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP(2019)125 cited
- → A caged E3 ligase ligand for PROTAC-mediated protein degradation with light(2020)121 cited
- → Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs(2021)113 cited
- → Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor(2019)87 cited
- → A Modular Probe Strategy for Drug Localization, Target Identification and Target Occupancy Measurement on Single Cell Level(2016)85 cited
- → Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives(2016)59 cited